<p>In this June 30, 2010 file photo, a pharmacist holds a bottle of Avandia pills at Maximart Pharmacy in Palo Alto, Calif.</p>
July 11, 2010
Stories this photo appears in:
July 11, 2010 9 p.m.
FDA review spotlights heart risk of diabetes pill
Meeting will decide whether Avandia will stay on market
WASHINGTON - Federal health scientists have panned a GlaxoSmithKline study that the company used to defend the safety of its embattled diabetes drug Avandia, a once blockbuster-seller that has fallen out of favor because of potential ties to heart attacks.